| Dr Ghazala Zafar, MD | |
|
135 Barclay Circle, Suite 100, Rochester, MI 48307 | |
| (248) 852-2277 | |
| (248) 852-2552 |
| Full Name | Dr Ghazala Zafar |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 45 Years |
| Location | 135 Barclay Circle, Rochester, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548278906 | NPI | - | NPPES |
| 104689062 | Other | MI | BLUECROSS OF MICHIGAN |
| 104689062 | Medicaid | MI | |
| 4301065025 | Other | MI | LICENSE NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 4301065025 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension Providence - Crittenton Hospital Medical Center | Rochester, MI | Hospital |
| Beaumont Hospital, Troy | Troy, MI | Hospital |
| Entity Name | Ghazala Zafar Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881808376 PECOS PAC ID: 3971510124 Enrollment ID: O20060313000329 |
News Archive
People with inherited diseases of the blood and immune system can now receive treatment at the National Institutes of Health Clinical Center through a new, streamlined program that integrates expertise from many medical specialties and related basic science disciplines.
Improvements in behavior and screening have contributed greatly to the 13 percent decline in cancer mortality since 1990, with better cancer treatments playing a supporting role, according to new research from David Cutler of Harvard University.
Aimmune Therapeutics, Inc., a privately held biopharmaceutical company developing desensitization treatments for food allergies, announced today that a Phase 2 study (ARC001) evaluating the company's lead investigational product, AR101 for the treatment of peanut allergy, met its primary endpoint and additional endpoint of desensitizing patients to cumulative amounts of peanut protein of 443 mg and 1,043 mg, respectively.
The date has been set - July 13 - for oral arguments to be heard in a California appeal of a lawsuit against the health overhaul filed by the Pacific Justice Institute. And, in Kansas, the attorney general has signed on to an amicus brief that supports, but does not join, in a lawsuit challenging the measure.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ghazala Zafar, MD 135 Barclay Circle, Suite 100, Rochester, MI 48307 Ph: (248) 852-2277 | Dr Ghazala Zafar, MD 135 Barclay Circle, Suite 100, Rochester, MI 48307 Ph: (248) 852-2277 |
News Archive
People with inherited diseases of the blood and immune system can now receive treatment at the National Institutes of Health Clinical Center through a new, streamlined program that integrates expertise from many medical specialties and related basic science disciplines.
Improvements in behavior and screening have contributed greatly to the 13 percent decline in cancer mortality since 1990, with better cancer treatments playing a supporting role, according to new research from David Cutler of Harvard University.
Aimmune Therapeutics, Inc., a privately held biopharmaceutical company developing desensitization treatments for food allergies, announced today that a Phase 2 study (ARC001) evaluating the company's lead investigational product, AR101 for the treatment of peanut allergy, met its primary endpoint and additional endpoint of desensitizing patients to cumulative amounts of peanut protein of 443 mg and 1,043 mg, respectively.
The date has been set - July 13 - for oral arguments to be heard in a California appeal of a lawsuit against the health overhaul filed by the Pacific Justice Institute. And, in Kansas, the attorney general has signed on to an amicus brief that supports, but does not join, in a lawsuit challenging the measure.
› Verified 6 days ago
Dr. Anil Singh, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1101 W University Dr, Rochester, MI 48307 Phone: 734-464-0887 Fax: 734-402-0254 | |
Dr. Kewal K Aggarwal, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1100 W University Dr, Rochester, MI 48307 Phone: 248-651-8200 Fax: 248-651-9546 | |
Dr. Delfin Santos, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 135 Barclay Circle, Suite 100, Rochester, MI 48307 Phone: 248-852-2277 Fax: 248-852-2552 | |
Noor Naji, Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1101 W University Dr # 3-north, Rochester, MI 48307 Phone: 248-601-4805 | |
Daniel Kapadia, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1101 W University Dr, Rochester, MI 48307 Phone: 734-377-4040 | |
Dr. Gina L Buccalo, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1135 W University Dr Ste 225, Rochester, MI 48307 Phone: 248-824-2570 Fax: 248-824-2571 | |
Frank Sottile, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1101 W University Dr, Rochester, MI 48307 Phone: 248-652-5000 |